CION Ameerpet
Burkitt lymphoma (sometimes written burkitts lymphoma) is one of the fastest growing cancers known — but it is also highly sensitive to intensive treatment and often curable when acted on quickly. This guide explains what it is, why speed matters, and how CION's haematology team responds within days.
Burkitt lymphoma is a rare but highly aggressive type of B-cell non-Hodgkin lymphoma. It belongs to the same broad family as diffuse large B-cell lymphoma (DLBCL), but it stands apart because of one striking feature: it is one of the fastest growing human cancers, with the number of tumour cells able to double in roughly a day. That is why it is often searched for simply as a "fast growing lymphoma".
At the heart of the disease is a change involving the MYC gene, a master switch for cell growth. When MYC is misplaced next to an antibody gene, it becomes stuck in the "on" position and the B-cells multiply relentlessly. Under the microscope, pathologists see a distinctive "starry-sky" appearance and a proliferation marker (Ki-67) close to 100% — almost every cell is dividing.
The speed of Burkitt lymphoma sounds frightening, and it does make prompt care essential. But the same rapid growth also makes it exceptionally sensitive to intensive chemotherapy, so with quick diagnosis and correctly-dosed treatment a large proportion of people — especially children and younger adults — can be cured. For the full picture of lymphoma care, see our Lymphoma hub and our Lymphoma Treatment in Hyderabad page.
Burkitt lymphoma is regarded as one of the fastest-growing human tumours — its cell population can roughly double in about 24 hours, and the proliferation marker Ki-67 is typically close to 100%, meaning nearly every cell is actively dividing. This is exactly why any suspected case is treated as a medical urgency, with diagnosis and treatment usually beginning within days. (Source: NCCN and ESMO B-cell lymphoma guidelines.)
Burkitt lymphoma is usually grouped into three clinical patterns. They share the same underlying MYC-driven biology but differ in who they affect and where they tend to start.
Seen mainly in equatorial Africa, most often in children. It classically causes a rapidly enlarging jaw or facial swelling and is very strongly linked to the Epstein-Barr virus (EBV), frequently alongside a background of chronic malaria.
The type most often seen in India and Western countries. It usually presents as a fast-growing abdominal mass — involving the bowel, its lymph nodes, or the ovaries or kidneys — and can affect both children and adults. The EBV link is weaker than in the endemic form.
Occurs in people with weakened immunity, particularly those living with untreated HIV. It highlights why an overall assessment — including immune status — is part of the work-up for any suspected Burkitt lymphoma.
Presentations vary by individual. Classification and management follow current NCCN and ESMO guidance.
Because Burkitt lymphoma grows so fast, the single most important factor is starting the right treatment quickly, delivered at full intensity and with the safeguards that intensive treatment demands. A delay of even a week can matter. Equally, the first cycle carries a real risk of tumour lysis syndrome — a rapid breakdown of cancer cells that can strain the kidneys — so it needs an experienced team and close monitoring.
At CION, suspected Burkitt lymphoma is fast-tracked. We coordinate an urgent biopsy, bone-marrow examination, PET-CT and the molecular tests (including MYC and the CD20 marker) needed to confirm the diagnosis, then plan care through a multidisciplinary tumour board — often within days. The intensive chemotherapy, anti-CD20 antibody therapy, central-nervous-system-directed treatment, supportive care and monitoring are all delivered directly by our haematology and medical-oncology team. If you are choosing where to be treated, see our Best Lymphoma Hospital in Hyderabad and Best Lymphoma Doctors in Hyderabad pages.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Just received a Burkitt lymphoma diagnosis, or worried about a rapidly growing lump or swelling? Because this is a fast growing lymphoma, our team fast-tracks reviews so treatment need not wait.
The hallmark of Burkitt lymphoma is how quickly symptoms appear and worsen — often over days rather than months. What you notice depends on where the disease starts. Common warning signs include:
Many of these symptoms have ordinary, non-cancer causes. But a lump or swelling that is new and clearly enlarging over days, especially with fevers, sweats or weight loss, should be assessed urgently. Speak to a CION haematologist if you have these signs or a confirmed diagnosis.
Confirming Burkitt lymphoma — and separating it from other aggressive B-cell lymphomas such as DLBCL and double-hit / high-grade B-cell lymphoma — takes an urgent, precise pathway. CION delivers the biopsy coordination, marrow exam, imaging and molecular testing directly.
An urgent biopsy of an affected node, mass or fluid is the essential first step. A haematopathologist looks for the classic "starry-sky" pattern and confirms a very high Ki-67 proliferation index. The cells' surface markers are checked, including the CD20 B-cell marker, which also guides antibody treatment.
The diagnosis is clinched by finding a MYC gene rearrangement (usually involving chromosomes 8 and 14) using specialised tests such as FISH. Because look-alike lymphomas can also carry MYC changes alongside other markers (for example BCL2), careful testing distinguishes true Burkitt lymphoma from high-grade "double-hit" lymphoma — a distinction that directly changes treatment.
A PET-CT scan, a bone-marrow examination and a sample of the fluid around the brain and spinal cord are done to map the extent of disease, because Burkitt lymphoma can involve the marrow and central nervous system. Blood tests, including markers of rapid cell turnover, help gauge risk and guide precautions for the first cycle. NCCN and ESMO guidelines expect this full staging before the plan is finalised.
Because Burkitt lymphoma cells break down so rapidly once treatment begins, the first cycle carries a real risk of tumour lysis syndrome — a surge of substances released from dying cells that can strain the kidneys and disturb blood chemistry. This is why the first cycle is usually given in hospital with close monitoring and preventive measures, and why an experienced team matters. (Source: NCCN and ESMO B-cell lymphoma guidelines.)
Unlike some slow-growing lymphomas, Burkitt lymphoma is never watched and waited — it needs prompt, intensive, curative-intent treatment. Every case is planned by CION's multidisciplinary tumour board, and the treatment is delivered directly by our team. The main building blocks are:
The backbone of treatment is several short but intensive cycles of combination chemotherapy, given close together to keep ahead of the fast-dividing cells. Because the disease responds so quickly, treatment is usually completed over a matter of months rather than years. CION's medical-oncology team delivers this chemotherapy directly. Specific regimen and drug names are covered on our Lymphoma Treatment in Hyderabad page.
Because Burkitt cells carry the CD20 marker, an anti-CD20 monoclonal antibody is added to chemotherapy. This targeted immunotherapy has improved outcomes and is delivered in-house alongside the chemotherapy cycles.
Burkitt lymphoma has a tendency to reach the brain and spinal cord, so treatment always includes therapy aimed there — medicine given into the spinal fluid and high-dose drugs that cross into the nervous system — to prevent or treat this involvement. This is a routine, planned part of every regimen.
The first cycle is usually given in hospital with active steps to prevent tumour lysis syndrome, along with support for blood counts, infection prevention and nutrition. If disease relapses or does not respond, more intensive options — which may include a stem-cell transplant or CAR-T cell therapy — are considered; these are coordinated through accredited partner facilities rather than delivered in-house. CION manages the referral and stays involved throughout.
The outlook for Burkitt lymphoma has improved markedly with modern intensive treatment. Published series report high cure rates in children and younger adults treated promptly with full-intensity, CNS-directed regimens, with outcomes generally lower in older adults or when the disease is very advanced at diagnosis. These figures come from large clinical series reported by NCCN and ESMO; they are averages, and outcomes vary from person to person depending on age, stage, general health and how the disease responds.
For context, aggressive B-cell lymphomas differ widely in outlook — for example DLBCL cure rates are commonly quoted around 60–70% in published series, while Hodgkin lymphoma is often around 80–90%. Burkitt lymphoma sits at the aggressive end for growth speed, yet its high sensitivity to chemotherapy means well-treated, promptly-diagnosed disease can carry a genuinely favourable outlook. What matters most is starting the correct treatment quickly. We will always discuss your individual outlook honestly, and we never promise a guaranteed cure.
Related reading in this cluster: Burkitt lymphoma in children, primary CNS lymphoma, and extranodal lymphoma (when it starts outside the lymph nodes).
Given how fast this disease moves, a second opinion is best sought quickly — but it is still worth doing, and is especially valuable in a few situations:
CION offers a free written second-opinion service, fast-tracked for aggressive lymphomas. You deserve a plan built around healing, not billing — with transparent costs explained up front. Request your free second opinion or call 18002028726.
Get a fast-tracked, free written second opinion from CION's lymphoma tumour board — especially valuable if MYC and CD20 testing has not yet been arranged, or the exact diagnosis is uncertain.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Burkitt lymphoma is a rare, highly aggressive form of B-cell non-Hodgkin lymphoma. It is one of the fastest growing human tumours — the number of cancer cells can double in about a day. It is driven by a change involving the MYC gene, which switches the cells into rapid, uncontrolled growth. Because it moves so quickly, Burkitt lymphoma is treated as a medical urgency: diagnosis and the start of treatment usually happen within days, not weeks. The upside of its fast pace is that it is also very sensitive to intensive chemotherapy, so with prompt, correctly-dosed treatment a large proportion of people can be cured. It affects both children and adults; see Burkitt lymphoma in children for the paediatric picture.
Burkitt lymphoma is described as a fast growing lymphoma because its cells have one of the highest proliferation rates of any cancer — a marker called Ki-67 is typically close to 100%, meaning almost every cell is actively dividing. A visible lump or an abdominal mass can enlarge noticeably over just a few days. This speed is why any suspected Burkitt lymphoma is worked up urgently and treatment is not delayed. The same rapid division that makes it dangerous also makes the cells very vulnerable to chemotherapy, which targets dividing cells — a key reason intensive short-course regimens work so well here. If you or a family member has a rapidly enlarging lump or swelling, speak to a CION haematologist without delay.
Symptoms appear and worsen quickly. In the common abdominal form, people notice a rapidly growing tummy swelling or mass, abdominal pain, fullness, nausea or a change in bowel habit. In other forms, fast-enlarging lymph nodes in the neck, jaw or elsewhere are the first sign — jaw and facial swelling is characteristic of the variety seen in parts of Africa. Because the disease multiplies so fast, "B symptoms" such as drenching night sweats, unexplained fevers and weight loss are common. Some people present with symptoms of a large tumour pressing on organs, or with the effects of the cancer spilling into the blood, marrow or the fluid around the brain. Any of these, especially when they escalate over days, need urgent review — a lymphoma specialist should assess you promptly.
Diagnosis starts with an urgent biopsy of an affected node, mass or fluid, examined by a haematopathologist. Under the microscope Burkitt cells show a classic "starry-sky" pattern, and the near-100% Ki-67 proliferation index points strongly to the diagnosis. It is confirmed by finding a MYC gene rearrangement (usually involving chromosomes 8 and 14) using specialised tests such as FISH, together with a B-cell marker profile. A bone-marrow examination, a PET-CT scan and a sample of the fluid around the brain and spinal cord are done to map how far it has spread, because Burkitt lymphoma can involve the marrow and central nervous system. CION delivers the biopsy, marrow exam, imaging and specialist review directly, coordinating rapidly so treatment can begin in days.
Yes — despite being one of the most aggressive lymphomas, Burkitt lymphoma is potentially curable, and its fast growth actually works in the patient's favour because the cells respond dramatically to intensive chemotherapy. Published series report high cure rates in children and younger adults treated with short, intensive, correctly-dosed regimens that include therapy directed at the brain and spinal cord, with outcomes somewhat lower in older adults or when the disease is very advanced (figures vary by individual and by risk group, per NCCN and ESMO). The two things that matter most are speed — starting the right treatment quickly — and getting the full-intensity regimen delivered safely. This is why prompt referral to an experienced team is so important. We describe outcomes honestly and never promise a guaranteed cure.
Burkitt lymphoma is treated with short, intensive courses of combination chemotherapy given in cycles, almost always combined with an anti-CD20 monoclonal antibody because the cells carry the CD20 marker. Crucially, treatment always includes therapy aimed at the brain and spinal cord (given into the spinal fluid and as high-dose drugs) to prevent or treat central-nervous-system involvement. Because the cancer breaks down so rapidly once treatment starts, careful measures are taken to prevent tumour lysis syndrome, so the first cycle is usually given in hospital with close monitoring. CION delivers the chemotherapy, antibody therapy, supportive care and monitoring directly, and every case is planned by a multidisciplinary tumour board. Specific regimen and drug names are discussed on our Lymphoma Treatment in Hyderabad page.
In many cases, yes — Burkitt lymphoma has a well-established link with the Epstein-Barr virus (EBV), the same common virus that causes glandular fever. The connection is strongest in the "endemic" African form, where nearly all cases carry EBV, often alongside a history of malaria; it is less common in the "sporadic" form seen in India and the West. Burkitt lymphoma is also more frequent in people with weakened immunity, such as those living with untreated HIV. Importantly, EBV infection is extremely common and only a tiny fraction of infected people ever develop lymphoma — having had EBV does not mean you will get Burkitt lymphoma. If you have concerns, our lymphoma doctors can explain your individual risk.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.